Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas

Clinical trial NCT01942629 · UNKNOWN

Trial details

NCT number: NCT01942629
Sponsor: Rambam Health Care Campus
Status: UNKNOWN
Study type: OBSERVATIONAL

Lung Adenocarcinoma Breast Adenocarcinoma Pancreatic Ductal Adenocarcinoma

Start date: 2013-10-01
Primary completion: 2015-10-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.